Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (81-90 of 332) with videos related to

Pageof 34
Sort By:
BJU International|June 20, 2008
Peroperative transrectal ultrasonography-guided bladder neck dissection eases the learning of robot-assisted laparoscopic prostatectomyHenk G van der Poel, Willem de Blok, Axel Bex, et al.
World Journal of Urology|February 3, 2016
Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapyAllard Noe, Roderick E de Bruijn, Christian Blank, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumorAxel Bex, Henk Mallo, Martijn Kerst, et al.
Urology|December 31, 2017
Robotic-assisted Laparoscopic Partial Nephrectomy in a Horseshoe Kidney. A Case Report and Review of the LiteratureAvi Raman, Teele Kuusk, Eoin R Hyde, et al.
Angiogenesis|April 13, 2017
Antiangiogenic therapy combined with immune checkpoint blockade in renal cancerTeele Kuusk, Laurence Albiges, Bernard Escudier, et al.
Urology|November 17, 2012
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentationBin K Kroon, Roderick de Bruijn, Warner Prevoo, et al.
The Journal of Urology|February 24, 2010
Re: Surgical resection of renal cell carcinoma after targeted therapyA. A. Thomas, B. I. Rini, A. J. Stephenson, J. A. Garcia, A. Fergany, V. Krishnamurthi, A. C. Novick, I. S. Gill, E. A. Klein, M. Zhou and S. C. Campbell J Urol 2009; 182: 881-886Axel Bex, Astrid A M van der Veldt, Epie Boven, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2010
Feasibility of sentinel node detection in renal cell carcinoma: a pilot studyAxel Bex, Lenka Vermeeren, Geraldine de Windt, et al.
BJU International|April 16, 2008
Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observationsWillem Meinhardt, Renato A Valdés Olmos, Henk G van der Poel, et al.
European Urology Oncology|June 20, 2020
Management of Metastatic Nonclear Renal Cell Carcinoma: What Are the Options and Challenges?Maria Carmen Mir, Laurence Albiges, Axel Bex, et al.
Pageof 34

Showing results (81-90 of 332) with videos related to

Sort By:
Pageof 34
BJU International|June 20, 2008
Peroperative transrectal ultrasonography-guided bladder neck dissection eases the learning of robot-assisted laparoscopic prostatectomyHenk G van der Poel, Willem de Blok, Axel Bex, et al.
World Journal of Urology|February 3, 2016
Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapyAllard Noe, Roderick E de Bruijn, Christian Blank, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumorAxel Bex, Henk Mallo, Martijn Kerst, et al.
Urology|December 31, 2017
Robotic-assisted Laparoscopic Partial Nephrectomy in a Horseshoe Kidney. A Case Report and Review of the LiteratureAvi Raman, Teele Kuusk, Eoin R Hyde, et al.
Angiogenesis|April 13, 2017
Antiangiogenic therapy combined with immune checkpoint blockade in renal cancerTeele Kuusk, Laurence Albiges, Bernard Escudier, et al.
Urology|November 17, 2012
Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentationBin K Kroon, Roderick de Bruijn, Warner Prevoo, et al.
The Journal of Urology|February 24, 2010
Re: Surgical resection of renal cell carcinoma after targeted therapyA. A. Thomas, B. I. Rini, A. J. Stephenson, J. A. Garcia, A. Fergany, V. Krishnamurthi, A. C. Novick, I. S. Gill, E. A. Klein, M. Zhou and S. C. Campbell J Urol 2009; 182: 881-886Axel Bex, Astrid A M van der Veldt, Epie Boven, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2010
Feasibility of sentinel node detection in renal cell carcinoma: a pilot studyAxel Bex, Lenka Vermeeren, Geraldine de Windt, et al.
BJU International|April 16, 2008
Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observationsWillem Meinhardt, Renato A Valdés Olmos, Henk G van der Poel, et al.
European Urology Oncology|June 20, 2020
Management of Metastatic Nonclear Renal Cell Carcinoma: What Are the Options and Challenges?Maria Carmen Mir, Laurence Albiges, Axel Bex, et al.
Pageof 34